Prevention and treatment of viral infections in stem cell transplant recipients.
Ljungman
Per
P
Department of Haematology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden. Per.Ljungman@medhs.ki.se
D000256:Adenoviridae; D000998:Antiviral Agents / Q000627:therapeutic use*; D002644:Chickenpox / Q000188:drug therapy / Q000517:prevention & control; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D016174:Hepacivirus; D006515:Hepatitis B virus; D006561:Herpes Simplex / Q000188:drug therapy / Q000517:prevention & control; D014645:Herpesvirus 3, Human; D015654:Herpesvirus 6, Human; D006801:Humans; D009975:Orthomyxoviridae; D030361:Papillomavirus Infections; D018184:Paramyxoviridae Infections / Q000188:drug therapy / Q000517:prevention & control; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000517:prevention & control / Q000821:virology; D018139:Simplexvirus; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000188:drug therapy / Q000517:prevention & control*
D000998:Antiviral Agents